#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3976	16S	1529	1529	99.8	16S.l15.c4.ctg.1	2552	464.5	0	.	n	.	0	C129T	SNP	129	129	C	645	645	T	627	T,C	379,163	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3976	16S	1529	1529	99.8	16S.l15.c4.ctg.1	2552	464.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1966	1966	T	599	T,A	538,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3976	16S	1529	1529	99.8	16S.l15.c4.ctg.1	2552	464.5	0	.	n	.	0	C1525T	SNP	1525	1525	C	2041	2041	T	602	T,C	312,219	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3976	16S	1529	1529	99.8	16S.l15.c4.ctg.1	2552	464.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1700	1700	C	565	C	501	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6528	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3809	513.3	0	.	n	.	0	T695C	SNP	695	695	T	1114	1114	C	529	C,T	457,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6528	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3809	513.3	0	.	n	.	0	G1365A	SNP	1365	1365	G	1784	1784	A	544	A,G	480,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6528	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3809	513.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2390	2390	C	593	C,A	517,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6528	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3809	513.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2464	2464	A	616	A,C	524,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6528	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3809	513.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3016	3016	C	599	C	506	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	610	folP	855	855	100.0	folP.l15.c4.ctg.1	1860	98.4	1	SNP	p	R229S	0	.	.	685	687	CGC	1174	1176	CGC	138;138;137	C;G;C,T	118;122;119,1	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	1350	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3725	108.8	1	SNP	p	S91F	1	.	.	271	273	TTC	736	738	TTC	139;138;138	T;T;C	118;119;119	gyrA.WHO_Z_01155:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	1350	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3725	108.8	1	SNP	p	D95N	1	.	.	283	285	AAC	748	750	AAC	135;135;136	A;A,T;C	116;116,1;119	gyrA.WHO_Z_01155:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	1350	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3725	108.8	1	SNP	p	N95G	0	.	.	283	285	AAC	748	750	AAC	135;135;136	A;A,T;C	116;116,1;119	gyrA.WHO_Z_01155:1:1:N95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	554	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1598	103.9	1	SNP	p	G45D	1	.	.	133	135	GAC	615	617	GAC	156;156;156	G;A;C	133;132;135	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	338	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1320	76.9	0	.	n	.	0	G120A	SNP	120	120	G	659	659	A	127	A	117	.	.
parC.WHO_L_00611c	parC.WHO_L_00611c	1	1	27	1224	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3236	113.4	1	SNP	p	D86N	1	.	.	256	258	AAC	720	722	AAC	130;130;129	A;A;C	114;117;118	parC.WHO_L_00611c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_L_00611c	parC.WHO_L_00611c	1	1	27	1224	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3236	113.4	1	SNP	p	S87R	0	.	.	259	261	AGT	723	725	AGT	128;129;128	A;G;T	116;116;117	parC.WHO_L_00611c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_L_00611c	parC.WHO_L_00611c	1	1	27	1224	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3236	113.4	1	SNP	p	S87I	0	.	.	259	261	AGT	723	725	AGT	128;129;128	A;G;T	116;116;117	parC.WHO_L_00611c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_L_00611c	parC.WHO_L_00611c	1	1	27	1224	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3236	113.4	1	SNP	p	S87W	0	.	.	259	261	AGT	723	725	AGT	128;129;128	A;G;T	116;116;117	parC.WHO_L_00611c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_L_00611c	parC.WHO_L_00611c	1	1	27	1224	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3236	113.4	1	SNP	p	S88P	1	.	.	262	264	CCC	726	728	CCC	129;130;132	C;C;C	119;116;117	parC.WHO_L_00611c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1138	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3035	112.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1741	1743	GGC	145;144;145	G;G;C	120;115;117	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.7.001	penA.7.001	1	1	27	1068	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2795	114.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1464	1466	GCA	145;145;145	G;C;A	127;129;128	penA.7.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	1068	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2795	114.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1467	1469	ATC	143;143;143	A;T;C	129;128;128	penA.7.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	1068	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2795	114.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1479	1481	GTG	143;142;143	G;T;G	129;125;128	penA.7.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	1068	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2795	114.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1479	1481	GTG	143;142;143	G;T;G	129;125;128	penA.7.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	1068	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2795	114.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1983	1985	ACC	145;146;146	A;C;C	129;128;129	penA.7.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	1068	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2795	114.7	1	SNP	p	A502V	1	.	.	1504	1506	GTG	2037	2039	GTG	150;150;153	G,T;T;G	121,1;109;117	penA.7.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	1068	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2795	114.7	1	SNP	p	V502P	0	.	.	1504	1506	GTG	2037	2039	GTG	150;150;153	G,T;T;G	121,1;109;117	penA.7.001:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	1068	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2795	114.7	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2160	2162	AGC	138;140;140	A;G;C	115;119;116	penA.7.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	1068	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2795	114.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2169	2171	GGC	141;140;138	G,C;G,T;C	119,1;121,1;118	penA.7.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	1068	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2795	114.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2187	2189	CCG	141;140;138	C;C;G	118;120;114	penA.7.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1434	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3402	126.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1758	1760	CCG	134;134;134	C;C;G	106;108;111	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	758	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2150	105.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	543	545	GGC	108;107;106	G;G;C	93;90;91	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	758	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2150	105.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	725	725	C	119	C	109	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	27	896	porB1b	1047	1047	100.0	porB1b.l6.c30.ctg.1	1867	142.9	1	SNP	p	G120K	1	.	.	358	360	AAG	809	811	AAG	181;179;181	A;A,C;G	156;153,1;157	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	27	896	porB1b	1047	1047	100.0	porB1b.l6.c30.ctg.1	1867	142.9	1	SNP	p	D121N	0	.	.	361	363	GAC	812	814	GAC	180;181;182	G;A;C	153;155;154	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	27	896	porB1b	1047	1047	100.0	porB1b.l6.c30.ctg.1	1867	142.9	1	SNP	p	A121D	1	.	.	361	363	GAC	812	814	GAC	180;181;182	G;A;C	153;155;154	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2984	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5212	171.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2145	2147	CAT	180;181;181	C;A,C;T	154;156,1;156	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	486	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1302	111.6	1	SNP	p	V57M	1	.	.	169	171	ATG	672	674	ATG	198;199;200	A;T;G	169;174;174	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
